{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T04:19:26Z","timestamp":1792210766288,"version":"4.4.0"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1097\/mcg.0b013e3182506dbb","type":"journal-article","created":{"date-parts":[[2012,5,15]],"date-time":"2012-05-15T10:24:20Z","timestamp":1337077460000},"page":"709-715","source":"Crossref","is-referenced-by-count":85,"title":["The Role of Rifaximin in the Primary Prophylaxis of Spontaneous Bacterial Peritonitis in Patients With Liver Cirrhosis"],"prefix":"10.1097","volume":"46","author":[{"given":"Mohamad A.","family":"Hanouneh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim A.","family":"Hanouneh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana G.","family":"Hashash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Law","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamak Modaresi","family":"Esfeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocio","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nyla","family":"Hazratjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nizar N.","family":"Zein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-18-20210305","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/hep.1840170215","article-title":"Spontaneous bacterial peritonitis in cirrhosis: predictive factors of infection resolution and survival in patients treated with cefotaxime.","volume":"17","author":"Toledo","year":"1993","journal-title":"Hepatology"},{"key":"R2-18-20210305","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1016\/0016-5085(91)90677-D","article-title":"Short-course versus long-course antibiotic treatment of spontaneous bacterial peritonitis: a randomized controlled study of 100 patients.","volume":"100","author":"Runyon","year":"1991","journal-title":"Gastroenterology"},{"key":"R3-18-20210305","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1002\/hep.1840210312","article-title":"Two different dosages of cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis: results of a prospective, randomized, multicenter study.","volume":"21","author":"Rimola","year":"1995","journal-title":"Hepatology"},{"key":"R4-18-20210305","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/hep.1840050319","article-title":"Cefotaxime is more effective than is ampicillin-tobramycin in cirrhotics with severe infections.","volume":"5","author":"Felisart","year":"1985","journal-title":"Hepatology"},{"key":"R5-18-20210305","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S0016-5085(96)70069-0","article-title":"Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis.","volume":"111","author":"Navasa","year":"1996","journal-title":"Gastroenterology"},{"key":"R6-18-20210305","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/hep.1840120416","article-title":"Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial.","volume":"12","author":"Gines","year":"1990","journal-title":"Hepatology"},{"key":"R7-18-20210305","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1002\/hep.1840170622","article-title":"Bacterial translocation in acute and chronic portal hypertension.","volume":"17","author":"Garcia-Tsao","year":"1993","journal-title":"Hepatology"},{"key":"R8-18-20210305","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0168-8278(88)80018-7","article-title":"Translocated intestinal bacteria cause spontaneous bacterial peritonitis in cirrhotic rats: molecular epidemiologic evidence.","volume":"28","author":"Llovet","year":"1998","journal-title":"J Hepatol"},{"key":"R9-18-20210305","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1002\/hep.510280504","article-title":"Small intestine dysmotility and bacterial overgrowth in cirrhotic patients with spontaneous bacterial peritonitis.","volume":"28","author":"Chang","year":"1998","journal-title":"Hepatology"},{"key":"R10-18-20210305","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/S0168-8278(97)80474-6","article-title":"Intestinal bacterial overgrowth and bacterial translocation in cirrhotic rats with ascites.","volume":"26","author":"Guarner","year":"1997","journal-title":"J Hepatol"},{"key":"R11-18-20210305","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/hep.1840040109","article-title":"Reticuloendothelial system phagocytic activity in cirrhosis and its relation to bacterial infections and prognosis.","volume":"4","author":"Rimola","year":"1984","journal-title":"Hepatology"},{"key":"R12-18-20210305","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3109\/00365528109182002","article-title":"Reticuloendothelial function in patients with alcoholic liver cirrhosis.","volume":"16","author":"Lahnborg","year":"1981","journal-title":"Scand J Gastroenterol"},{"key":"R13-18-20210305","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/0016-5085(86)90185-X","article-title":"Low-protein-concentration ascitic fluid is predisposed to spontaneous bacterial peritonitis.","volume":"91","author":"Runyon","year":"1986","journal-title":"Gastroenterology"},{"key":"R14-18-20210305","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/hep.1840080107","article-title":"Recurrence of spontaneous bacterial peritonitis in cirrhosis: frequency and predictive factors.","volume":"8","author":"Tito","year":"1988","journal-title":"Hepatology"},{"key":"R15-18-20210305","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/0002-9343(78)90578-8","article-title":"Spontaneous bacterial peritonitis. A review of 28 cases with emphasis on improved survival and factors influencing prognosis.","volume":"64","author":"Weinstein","year":"1978","journal-title":"Am J Med"},{"key":"R16-18-20210305","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/0016-5085(91)90219-B","article-title":"Selective intestinal decontamination prevents spontaneous bacterial peritonitis.","volume":"100","author":"Soriano","year":"1991","journal-title":"Gastroenterology"},{"key":"R17-18-20210305","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1053\/j.gastro.2007.06.065","article-title":"Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis.","volume":"133","author":"Fernandez","year":"2007","journal-title":"Gastroenterology"},{"key":"R18-18-20210305","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1002\/hep.510290406","article-title":"Infections caused by Escherichia coli resistant to norfloxacin in hospitalized cirrhotic patients.","volume":"29","author":"Ortiz","year":"1999","journal-title":"Hepatology"},{"key":"R19-18-20210305","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1053\/jhep.2002.30082","article-title":"Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis.","volume":"35","author":"Fernandez","year":"2002","journal-title":"Hepatology"},{"issue":"suppl 4","key":"R20-18-20210305","first-page":"106A","article-title":"Intestinal antibacterial activity of a new rifamycin derivative: compound L-105.","volume":"1","author":"Berti","year":"1982","journal-title":"Chemioterapia (Florence)"},{"key":"R21-18-20210305","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1006\/phrs.2001.0869","article-title":"Effects of daily oral administration of rifaximin and neomycin on faecal aerobic flora in rats.","volume":"44","author":"Miglioli","year":"2001","journal-title":"Pharmacol Res"},{"key":"R22-18-20210305","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1179\/joc.2008.20.2.186","article-title":"Effects of rifaximin on bacterial virulence mechanisms at supra- and sub-inhibitory concentrations.","volume":"20","author":"Debbia","year":"2008","journal-title":"J Chemother"},{"key":"R23-18-20210305","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/j.1469-0691.2004.00997.x","article-title":"Influence of rifaximin treatment on the susceptibility of intestinal Gram-negative flora and enterococci.","volume":"10","author":"DuPont","year":"2004","journal-title":"Clin Microbiol Infect"},{"key":"R24-18-20210305","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1179\/joc.2002.14.3.290","article-title":"Effects of rifaximin administration on the intestinal microbiota in patients with ulcerative colitis.","volume":"14","author":"Brigidi","year":"2002","journal-title":"J Chemother"},{"key":"R25-18-20210305","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1056\/NEJMoa0907893","article-title":"Rifaximin treatment in hepatic encephalopathy.","volume":"362","author":"Bass","year":"2010","journal-title":"N Engl J Med"},{"key":"R26-18-20210305","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.3748\/wjg.15.2628","article-title":"Small intestine bacterial overgrowth and irritable bowel syndrome-related symptoms: experience with rifaximin.","volume":"15","author":"Peralta","year":"2009","journal-title":"World J Gastroenterol"},{"key":"R28-18-20210305","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1086\/511870","article-title":"Interruption of recurrent Clostridium difficile-associated diarrhea episodes by serial therapy with vancomycin and rifaximin.","volume":"44","author":"Johnson","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R29-18-20210305","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1002\/hep.22853","article-title":"Management of adult patients with ascites due to cirrhosis: an update. AASLD practice guidelines.","volume":"49","author":"Runyon","year":"2009","journal-title":"Hepatology"},{"key":"R30-18-20210305","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1111\/j.1365-2036.2009.03994.x","article-title":"Small-intestinal bacterial overgrowth in cirrhosis is related to the severity of liver disease.","volume":"29","author":"Pande","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"R31-18-20210305","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1053\/j.gastro.2010.06.019","article-title":"Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis.","volume":"139","author":"Arvaniti","year":"2010","journal-title":"Gastroenterology"},{"key":"R32-18-20210305","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0025-7125(05)70309-6","article-title":"Antibiotic side effects.","volume":"85","author":"Cunha","year":"2001","journal-title":"Med Clin North Am"},{"key":"R33-18-20210305","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1023\/A:1026649730012","article-title":"Effect of long-term trimethoprim-sulfamethoxazole prophylaxis on ascites formation, bacterial translocation, spontaneous bacterial peritonitis, and survival in cirrhotic rats.","volume":"44","author":"Guarner","year":"1999","journal-title":"Dig Dis Sci"},{"key":"R34-18-20210305","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1002\/hep.23918","article-title":"Bacterial DNA translocation is associated with systemic circulatory abnormalities and intrahepatic endothelial dysfunction in patients with cirrhosis.","volume":"52","author":"Bellot","year":"2010","journal-title":"Hepatology"},{"key":"R35-18-20210305","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1111\/j.1365-2036.2009.03958.x","article-title":"Intestinal decontamination improves liver haemodynamics in patients with alcohol-related decompensated cirrhosis.","volume":"29","author":"Vlachogiannakos","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"R36-18-20210305","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1046\/j.1365-2036.2000.00751.x","article-title":"Rifaximin versus chlortetracycline in the short-term treatment of small intestinal bacterial overgrowth.","volume":"14","author":"Di Stefano","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"key":"R37-18-20210305","first-page":"1719","article-title":"Effect of selective bowel decontamination with norfloxacin on spontaneous bacterial peritonitis, translocation, and survival in an animal model of cirrhosis.","volume":"21","author":"Runyon","year":"1995","journal-title":"Hepatology"},{"key":"R38-18-20210305","first-page":"979","article-title":"Rapid disappearance from the intestinal tract of bacteria resistant to rifaximin.","volume":"12","author":"De Leo","year":"1986","journal-title":"Drugs Exp Clin Res"},{"key":"R39-18-20210305","doi-asserted-by":"crossref","first-page":"467","DOI":"10.2165\/00003495-199549030-00009","article-title":"Rifaximin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential in conditions mediated by gastrointestinal bacteria.","volume":"49","author":"Gillis","year":"1995","journal-title":"Drugs"},{"key":"R41-18-20210305","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/ajg.2009.80","article-title":"Association of proton pump inhibitor therapy with spontaneous bacterial peritonitis in cirrhotic patients with ascites.","volume":"104","author":"Bajaj","year":"2009","journal-title":"Am J Gastroenterol"}],"container-title":["Journal of Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00004836-201209000-00018","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T06:27:33Z","timestamp":1618036053000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004836-201209000-00018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":39,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/mcg.0b013e3182506dbb","relation":{},"ISSN":["0192-0790"],"issn-type":[{"value":"0192-0790","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}